Hyltander AG - Search Results

1

Jabbar KS, Verbeke C, Hyltander AG, Sjövall H, Hansson GC, Sadik R. Jabbar KS, et al. Among authors: hyltander ag. J Natl Cancer Inst. 2014 Oct 29;106(11):dju330. doi: 10.1093/jnci/dju330. Print 2014 Nov. J Natl Cancer Inst. 2014. PMID: 25359854 Free PMC article. No abstract available.

2

Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.

Jabbar KS, Verbeke C, Hyltander AG, Sjövall H, Hansson GC, Sadik R. Jabbar KS, et al. Among authors: hyltander ag. J Natl Cancer Inst. 2014 Feb;106(2):djt439. doi: 10.1093/jnci/djt439. J Natl Cancer Inst. 2014. PMID: 24523528 Free PMC article.

3

Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.

Lundholm K, Gunnebo L, Körner U, Iresjö BM, Engström C, Hyltander A, Smedh U, Bosaeus I. Lundholm K, et al. Cancer. 2010 Apr 15;116(8):2044-52. doi: 10.1002/cncr.24917. Cancer. 2010. PMID: 20186829 Free article. Clinical Trial.

4

Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors.

Lundholm K, Gelin J, Hyltander A, Lönnroth C, Sandström R, Svaninger G, Körner U, Gülich M, Kärrefors I, Norli B, et al. Lundholm K, et al. Cancer Res. 1994 Nov 1;54(21):5602-6. Cancer Res. 1994. PMID: 7923204 Clinical Trial.

5

Cost-utility estimations of palliative care in patients with pancreatic adenocarcinoma: a retrospective analysis.

Ljungman D, Hyltander A, Lundholm K. Ljungman D, et al. World J Surg. 2013 Aug;37(8):1883-91. doi: 10.1007/s00268-013-2003-z. World J Surg. 2013. PMID: 23519293

6

Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.

Ljungman D, Lundholm K, Hyltander A. Ljungman D, et al. World J Surg. 2011 Mar;35(3):662-70. doi: 10.1007/s00268-010-0883-8. World J Surg. 2011. PMID: 21132294

7

Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.

Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Fouladiun M, et al. Cancer. 2005 May 15;103(10):2189-98. doi: 10.1002/cncr.21013. Cancer. 2005. PMID: 15822132 Free article.

8

Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients.

Lindholm E, Daneryd P, Körner U, Hyltander A, Fouladiun M, Lundholm K. Lindholm E, et al. Clin Cancer Res. 2004 Oct 15;10(20):6855-64. doi: 10.1158/1078-0432.CCR-04-0373. Clin Cancer Res. 2004. PMID: 15501962 Clinical Trial.

9

Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.

Hyltander A, Daneryd P, Sandström R, Körner U, Lundholm K. Hyltander A, et al. Eur J Cancer. 2000 Feb;36(3):330-4. doi: 10.1016/s0959-8049(99)00273-7. Eur J Cancer. 2000. PMID: 10708933 Clinical Trial.

10

Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.

Lundholm K, Daneryd P, Körner U, Hyltander A, Bosaeus I. Lundholm K, et al. Int J Oncol. 2004 Mar;24(3):505-12. Int J Oncol. 2004. PMID: 14767534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters